Wein, W;Roper, B;Navab, N.Automatic registration and fusion of ultrasound with CT for radiotherapy.LECT NOTE COMPUT SCI.2005.3750.303-311

Kaulich, TW;Zurheide, J;Haug, T;Nüsslin, F;Bamberg, M.Clinical quality assurance for 106Ru ophthalmic applicators..Radiother Oncol.2005.76.1.86-92

Baum, C;Birkner, M;Alber, M;Paulsen, F;Nüsslin, F.Dosimetric consequences of the application of off-line setup error correction protocols and a hull-volume definition strategy for intensity modulated radiotherapy of prostate cancer..Radiother Oncol.2005.76.1.35-42

Andratschke, N;Nieder, C;Stark, S;Grosu, A;Wiedenmann, N;Busch, R;Kneschaurek, P;Molls, M.Intracranial arteries as organs at risk in fractionated stereotactic and intensity-modulated radiotherapy for skull base tumors.Eur J Cancer.2005.3 Suppl. S.2.412-412

Cai, L;Weber, W;Andratschke, N;Astner, S;Schill, S;Busch, R;Schwaiger, M;Nieder, C.A model of experimental kidney irradiation for screening of response modifiers: evaluation of insulin-like growth factor-1 (IGF-1) and a chemical p53 inhibitor.Eur J Cancer.2005.3 Suppl. S.2.395-395

Roper, B;Nuse, N;Zimmermann, FB;Pigorsch, S;Busch, R;Nahrig, J;Molis, M.Sonographic maximal malignancy criteria count (MMCC) of lymph nodes predicts progression and survival in H&N cancer stage IVA - a new prognostic factor.Eur J Cancer.2005.3 Suppl. S.2.306-306

Thamm, R;Geinitz, H;Zimmermann, F;Andratschke, C;Busch, R;Molis, M.Effectiveness and side effects of conformal radiation therapy after radical prostatectomy for prostate cancer.Eur J Cancer.2005.3 Suppl. S.2.239-239

Golclne, G;Zimmermann, F;Becker, G;Wachter, S;Geinitz, H;Feldmann, H;Poetzi, R;Bamberg, M;Molis, M;Poetter, R.Proctitis after 3D-conformal radiotherapy of localised prostate cancer classification according to the.Eur J Cancer.2005.3 Suppl. S.2.238-238

Geinitz, H;Zimmermann, F;Scholz, C;Prause, N;Winkler, C;Keller, M;Busch, R;Molis, M.Longitudinal evaluation of quality of life and rectal toxicity in patients with conformal radiation therapy for prostate cancer.Eur J Cancer.2005.3 Suppl. S.2.232-233

Nieder, C;Andratschke, N;Grosu, A;Thamm, R;Molls, M.Tumor volume reduction from 3 Gy-fractions measured in brain metastases and implications for clinical trials of response modifiers.Eur J Cancer.2005.3 Suppl. S.2.140-141